INTRODUCTION
============

Despite accessibility to different antibiotics, Urinary tract infections (UTIs) are the second most frequent community-acquired adult infection and the main cause of nosocomial infection \[[@B1]\]. *E. coli*is one of the major causes of nosocomial infections, especially in patients in intensive care units and the main cause of UTI in developed world, accounting for 70-90% of uncomplicated UTIs \[[@B2]\].

Understanding the molecular mechanism of resistance genes may help to the introduction of new antimicrobial strategies and some preventive procedures to prevent further spreading of resistance determinants among the pathogens \[[@B3]\]. Several resistance genes encode different mechanisms of drug resistance in bacterial genomes and in extra-chromosomal pieces of DNA \[[@B4]\].

Multidrug resistance (MDR) is a major problem worldwide and encoded by resistance genes exists on integrons. Integrons are mobile genetic elements considered to be responsible for the MDR transfer. Most of the integrons reported in clinical isolates are class 1 inegrons. Class 1 integrons carry integrase gene (*intI1*), which codes for the site-specific recombinase responsible for cassette insertion \[[@B5], [@B6]\]. Integrase gene also includes  the *attI1* site, where the cassettes are integrated and a promoter, Pc, is  responsible for the transcription of the cassette-encoded genes \[[@B5], [@B7]\]. Gene cassette contains a single antibiotic resistance gene and a 59-base element (or *attC* site) downstream of the gene, which is responsible for recombination events \[[@B8]\].

Extended spectrum beta lactamases (ESBLs) are a group of enzymes that are common among Enterobacteriaceae \[[@B9]\]. They are the increasingly important cause of transferable MDR in Gram-negative bacteria throughout the world. ESBLs also have the ability to hydrolyze third and fourth generation cephalosporins and monobactams. ESBL-producing strains are prevented by lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) \[[@B10]\].

ESBL-encoding genes are generally located on conjugative plasmids (such as *blaTEM*or *blaSHV*), although many of the most newly described ESBL genes are usually found within integron-like structures (such as *blaCTX*-*M*, *blaGES*, or *blaVEB*-*1*) \[[@B11]-[@B13]\]. On the other hand, ESBL-producing isolates usually show resistance to other antibiotics including aminoglyc-sides, tetracyclines, chloramphenicol, trimethoprim, sulfonamides, or quinolones. Resistance to these antibiotics is mostly related to presence of different resistance genes on plasmids, transposons, or integrons as transferable elements or genetic structures generated by combinatorial evolution of different interactive pieces \[[@B13]-[@B15]\]. The presence of ESBL genes on integrons can facilitate the distribution of such genetic elements \[[@B11], [@B12]\].

The aim of this study was to identify whether there are mechanisms of resistance in the *E. coli* isolates causing UTIs from north of Iran or not.

MATERIALS AND METHODS
=====================

***Sample collection and identification of bacterial strains.***Urine samples were collected from appropriate patients in early morning mid-stream using sterile, wide mouthed glass bottles with screw cap tops between May and July 2012. Samples were maintained in an icebox until laboratory analysis. It did not last more than one hour between sample collection and sample analysis. Urine samples were cultured on nutrient, blood and MacConkey agar plates and incubated at 37°C for 18-24 h. The usual bacteriological methods were applied for cultivation, isolation and identification of isolates from urine samples. The isolates were stored at -70ºC in a tryptic soy broth containing 15% glycerol until processing. The isolates were entitled as E1 to E33.

***Antimicrobial susceptibility test.***According to *Clinical and Laboratory Standards Institute (*CLSI) \[[@B16]\], disc diffusion test was applied to identify the susceptibility of the isolates to the following antimicrobials: piperacillin (100 μg), streptomycin (10 μg), tetracycline (30 μg), chloramphenicol (30 μg), cefepime (30 μg), ceftriaxone (30 μg), ceftazidime (30 μg), cephalothin (30 μg), cefotaxime (30 μg), cefuroxime (30 μg), imipenem (10 μg), amoxicillin-clavulanic acid (20/10 μg), and ciprofloxacin (5 μg). *E. coli* ATCC 25922 and ATCC 35218 were used as the reference strains to control the quality of the applied antimicrobial agents. MDRs were described as resistance to three or more antimicrobials.

***Phenotypic detection of ESBLs*** **.**Double-disk synergy tests were performed by placing disks of ceftazidime, cefotaxime, and cefepime (30 μg each) at 30 or 20 mm distance (center to center) from a disk containing amoxicillin (20 μg) and clavulanic acid (10 μg). When the cephalosporin zone was expanded by the clavulanate, ESBL production was supposed. It means that the zones produced by the disks with clavulanate were ≥5 mm larger than those without any inhibitor \[[@B16]\].

***Detection of class 1 integrons by PCR.***The existence of class 1 integrons was identified by PCR using specific primers for the integron integrase genes *intI1* ([Table 1](#T1){ref-type="table"}). A single colony of each isolate was suspended in 25 ml reaction mixture containing 2.5 ml 10× PCR, 1.5 ml 50 mM MgCl~2~, 2 ml 2.5 mM dNTP, 1 ml primer (forward and reverse) together with 1 unit *Taq*DNA polymerase (5 U/ml). Volume of the reaction mixture was adjusted by adding filtered deionized water. PCR assays were performed in a DNA thermal cycler (BioRad, USA). The PCR conditions were initial denaturation at 94ºC for 12 min, followed by 30 cycles of 1 min at 94ºC, 30 s at 60ºC for annealing, 2 min at 72ºC for elongation, and final extension was conducted at 72°C for 10 min. A reagent blank was included in every PCR assay containing all components of the reaction mixture except for the bacteria. ATCC *E. coli*25922 strain was used as negative control for all PCR assays, and *E. coli*ur-31 was used as positive control for *intI1* gene. PCR products were subjected to horizontal gel electrophoresis on 1% agarose gel (type II, Sigma, USA) in Tris-borate EDTA buffer at 100 volt (50 mA) at room temperature for 1 h. DNA bands were visualized by gel staining with ethidiumbromide (0.5 mg/ml) for 30 min and then photographed \[[@B17]\].

###### 

Oligonucleotide primers used in the PCR analysis

  **Primer**   **Oligoneucleotide sequence (5** **´** **-3** **´** **)**   **Amplicon size (bp)**
  ------------ ----------------------------------------------------------- ------------------------
  Int1F        GGTCAAGGATCTGGATTTCG                                        491
  Int1R        ACATGCGTGTAAATCATCGTC                                       491
  5́-CS         GGCATCCAAGCAGCAAG                                           variable
  3́-CS         AAGCAGACTTGACCTGA                                           variable

###### 

Antibiotic resistance profiles for ESBL and non-ESBL*E. coli* isolates

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Antimicrobial agents (µg)**         **Diffusion zone (mm)**   **ESBL isolates**\              **Non-ESBL isolates**\      ***P*** **value**                          
                                                                  **(n = 8)**                     **(n = 25)**                                                           
  ------------------------------------- ------------------------- -------------------- ---------- ------------------------ -- ------------------- --------- --------- -- ------
  Streptomycin (10 )                    ≤11                       0 (0)                5 (62.5)   3 (37.5)                    4 (16)              12 (48)   9 (36)       0.01

  Cefepime (30)                         ≤14                       1 (12.5)             2 (25)     5 (62.5)                    13 (52)             3 (12)    9 (36)       0.01

  Ceftriaxone (30)                      ≤13                       1 (12.5)             0 (0)      7 (87.5)                    9 (36)              4 (16)    12 (48)      0.01

  Amoxicillin-clavulanic acid (20/10)   ≤13                       0 (0)                0 (0)      8 (100)                     1 (4)               3 (12)    21 (84)      0.01

  Chloramphenicol (30)                  ≤12                       3 (37.5)             0 (0)      5 (62.5)                    14 (56)             1 (4)     10 (40)      0.01

  Ceftazidime (30)                      ≤14                       2 (25)               2 (25)     4 (50)                      10 (40)             2 (8)     13 (52)      0.01

  Ciprofloxacin (5)                     ≤15                       3 (37.5)             2 (25)     3 (37.5)                    12 (48)             5 (20)    8 (32)       Ns\*

  Imipenem (10)                         ≤15                       2 (25)               1 (12.5)   5 (62.5)                    16 (64)             3 (12)    6 (24)       0.01

  Cephalothin (30)                      ≤14                       0 (0)                0 (0)      8 (100)                     5 (20)              0 (0)     20 (80)      0.01

  Cefotaxime (30)                       ≤14                       1 (12.5)             0 (0)      7 (87.5)                    7 (28)              5 (20)    13 (52)      0.01

  Tetracyclines (10)                    ≤11                       0 (0)                0 (0)      8 (100)                     4 (16)              2 (8)     19 (76)      0.01

  Cefuroxime (30)                       ≤14                       0 (0)                1 (12.5)   7 (87.5)                    6 (24)              3 (12)    16 (64)      0.01

  Piperacillin(100)                     ≤11                       7 (87.5)             1 (12.5)   0 (0)                       22 (88)             2 (8)     1 (4)        Ns
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

***Detection of gene cassettes.***To characterize the gene cassettes inserted in the class 1 integrons, the fragments including the cassette regions were amplified by PCR. The primers used to amplify cassettes of class 1 integrons were 5́CS and 3́CS ([Table 1](#T1){ref-type="table"}) as mentioned previously \[[@B18]\].

RESULTS
=======

***Antimicrobial resistance.***The resistance patterns of the 33 urinary isolates are shown in the [Table 2](#T2){ref-type="table"}. All *E. coli* isolates (33 strains) were identified as multi-drug resistant. More than 50% of the isolates were resistant to tetracycline, cephalothin, cefuroxime, amoxicillin-clavulanic acid, and third generation cephalosporines. Nearly all isolates displayed sensitivity to piperacillin.

***ESBL screening.***Screening of ESBLs by double-disc synergy test indicated that eight isolates (24%) were ESBL producers. Phenotypic confirmatory disc diffusion test confirmed that 8 of the 33 isolates were ESBL producers. All ESBL isolates were completely resistant to tetracyclines, cephalothin and amoxicillin-clavulanic acid, but rates of resistance to other antibiotics were as bellow: amoxicillin-clavulanic acid 100%, cephalothin 100%, tetracycline 100%, ceftriaxone 87.5%, cefotaxime 87.5%, cefuroxime 87.5%, chloramphenicol 62.5%, cefepime 62.5%, imipenem 62%, ceftazidime 50%, streptomycin 37.5%, ciprofloxacin 37.5%. Antibiotic resistance profiles for ESBL and non-ESBL isolates are shown in [Table 2](#T2){ref-type="table"}. According to the Table, there was a significant correlation between ESBL production and resistance to all antibiotics except for ciprofloxacin and piperacillin (*P* \< 0.01).

***Detection of class 1 integrons and gene cassettes.***PCR analysis revealed that 32 strains (97%) contained *IntI1* gene ([Fig. 1](#F1){ref-type="fig"}). Among the eight ESBL-producing strains, seven had class 1 integrons. The detected fragment size was 483 bp. The strains including integrons had variable gene cassettes ([Fig. 2](#F2){ref-type="fig"}). One or maximum four gene cassettes was carried by class 1 integrons. Based on PCR amplification with primers 5́CS and 3́CS, the inserted gene cassettes of class 1 integrons were identified as 100, 250, 500, and 700 bp. The isolates similar in the number of gene cassettes were compared based on the results of disk diffusion ([Table 3](#T3){ref-type="table"}). Some isolates were similar in the size of gene cassettes, which seemed that they were different in the resistance profiles; however, some other had similar resistance profiles.

![PCR amplification of *IntI1* gene among some MDR *E. coli* isolates on 0.7% agarose gel. In all isolates, a fragment of 483 bp was detected. Lane L: DNA ladder. Lane 1, *E. coli* ATCC 25922 as a positive control for *IntI1*gene; Lanes 2-15, Amplified gene of *IntI1*in the tested clinical isolates](ibj-19-233-g001){#F1}

![The amplified gene cassettes with different sizes in the tested clinical isolates (1-33). L, DNA ladder](ibj-19-233-g002){#F2}

DISSCUSION
==========

Multi-drug resistant bacteria have been recently a problem in hospitalized patients worldwide. The frequency of MDR among clinical isolates is highly variable throughout the world and in different geographic areas and is rapidly changing according to time \[[@B19]\]. MDRs encoded by linked resistance genes exist  on integrons, which are potentially movable genetic elements supposed to be involved in transferring MDR. This study was designed to examine the drug resistance pattern, the frequency of the class 1 integrons and ESBLs among the MDR *E. coli*isolates in UTI patients in north of Iran, Rasht.

Based on the results, *E*. *coli*was the most frequent microorganism isolated from urine samples. Other investigators also reported that *E*. *coli*was the most commonly isolated aerobic microorganism from UTIs \[[@B20], [@B21]\]. In our study, similar to Salem *et al.* survey \[[@B17]\], all *E. coli* isolates were recognized as MDR. In Ahangarzadeh Rezaee *et al.* study \[[@B22]\], 84.2% of the isolates were multi-drug resistant.

Nearly all *E. coli*isolates in this survey were sensitive to p*iperacillin, while* some of them were resistant to other antimicrobials. The isolates displayed variable patterns of resistance to different antibiotics. More than 50% of the isolates were resistant to tetracycline, cephalothin, cefuroxime, amoxicillin-clavulanic acid, and third generation cephalosporines. According to Salem *et al.*\[[@B17]\], all *E. coli*isolates displayed resistance to penicillins, amoxicillin, cephalexin, and chloramphenicol. The isolates showed variable patterns of resistance to tetracycline, sulfamethoxazole-trimethoprim, erythromycin, and quinolone group.

In Ahangarzadeh Rezaee *et al*. \[[@B22]\] study on *E*. *coli*isolates from north-west of Iran, antibiotic resistance patterns were as follows: amoxicillin 99.3%, cephalothin 77.8%, co-trimoxazole 75%, tetracycline 72.8%, nalidixic acid 60.7%, norfloxacin 50.7%, ciprofloxacin 47.6%, ceftazidime 46.4%, gentamicin 33.6%, chloramphenicol 20.7%, nitrofurantoin 12.9%, amikacin 12.1%, and imipenem 1.4%.

The antimicrobial resistance genes located on integron-like structures are being dramatically reported worldwide \[[@B11]\]. Most of the newly described ESBL genes are generally found within integron-like structures (such as *blaCTX*-*M*, *blaGES*, or *blaVEB*-*1*) \[[@B11], [@B13]\]. On the other hand, ESBL-producing isolates are usually resistant to other antibiotics, such as aminoglycosides, tetracyclines, chloramphenicol etc. The fact that ESBL genes could be acquired by strains including particular integrons enlarges the possibilities of the selection of these strains by a variety of different antimicrobials. In addition, ESBL genes can be located on integrons, which may simplify the distribution of such genetic elements \[[@B11], [@B12]\].

###### 

The relation between resistance profiles and the number of gene cassettes

  -------------------------------------------------------------------------------------------
  **Isolates**         **Resistance**                 **Number of**\       **Band(s)**\
                                                      **gene cassettes**   **size (bp)**
  -------------------- ------------------------------ -------------------- ------------------
  E6, E7               Amoxicillin-clavulanic acid\   1                    250
                       Tetracyclines                                       

                                                                           

  E1, E2               Chloramphenicol\               2                    250, 500
                       Tetracyclines                                       

                                                                           

  E17, E19\            Streptomycin\                  2                    100, 500
  E22, E23, E24, E25   Amoxicillin-clavulanic acid\                        
                       Cephalothin\                                        
                       Tetracyclines\                                      
                       Ceftriaxone\                                        
                       Chloramphenicol\                                    
                       Cephalothin\                                        
                       Tetracyclines                                       

                                                                           

  E8, E9               Amoxicillin-clavulanic acid\   2                    250, 500
                       Ceftazidime\                                        
                       Cephalothin\                                        
                       Tetracyclines\                                      
                       Cefuroxime                                          

                                                                           

  E12, E15             Amoxicillin-clavulanic acid\   2                    250, 500
                       Ceftazidime\                                        
                       Cephalothin\                                        
                       Cefotaxime                                          

                                                                           

  E16, E18             Amoxicillin-clavulanic acid\   4                    100, 250,500,700
                       Ceftriaxone\                                        
                       Ceftazidime\                                        
                       Cephalothin\                                        
                       Cefotaxime\                                         
                       Cefuroxime                                          
  -------------------------------------------------------------------------------------------

For detection of class 1 integrons and ESBLs in this study, PCR amplification of *intI1* gene and Double-disk synergy test method were used, respectively. Based on the results, 97% and 24% of the isolates contained class 1 integrons (483 bp in size) and ESBLs, respectively, which is indicative of very high frequency of occurrence of class 1 integrons in *E. coli*strains. Also, nearly all ESBL isolates carried class 1 integrons.

In 2008, Phongpaichit *et al*. \[[@B23]\] studied the susceptibility of 175 *E. coli* isolates from stools against 12 antimicrobial agents and also the presence of class 1 integrons. Their results indicated that 63% of the isolates included class 1 integrons, and the majority of the isolates (85%) were resistant to at least one antimicrobial agent with the following resistance rate: streptomycin 66%, tetracycline 60%, sulfamethoxazole 59%, ampicillin 52%, trimethoprim-sulfamethoxazole 47%, kanamycin 30%, nalidixic acid 27%, ciprofloxacin 23%, norfloxacin 22%, amoxicillin-clavulanic acid 16%, gentamicin 8%, and amikacin 2%*.*

The presence of class 1 and class 2 integrons were also investigated in Salem *et al*. study \[[@B17]\]. The results indicated that the class 1 integrons were observed in *E. coli*isolates (54%), and *IntI1* gene yielded a DNA fragment of 1900 bp upon amplification by PCR, but class 2 integrons showed negative results. The absence of *IntI2* gene may be attributed that class 2 integrons found in 4 to 20% uropathogenic *E. coli*strains \[[@B24], [@B25]\] as well as in other human pathogens \[[@B26]\], other animal pathogens \[[@B27]\], and various commensal bacteria \[[@B28], [@B29]\]. Essen-Zandbergen *et al*. \[[@B30]\], reported that among all *E. coli* isolated from animals, class 1 integrons were found in 76%, and the size of gene cassettes were 600, 1000, 1550, 2000, 2200, and 2500 bp. Martinez-Freijo *et al*. \[[@B31]\] study represented that 62% of *E. coli* isolates were integron 1-positive and had different sizes of inserted gene cassette, including 1500, 1600, 1800, 2000, and 3000 bp. In Farshad *et al.*\[[@B32]\] study performed in Shiraz (Iran), of 96 *E. coli* isolates from urine samples tested, 6.25% of the strains were the integron 1-positive isolates. In other words, the prevalence of class 1 integrons among the isolates was low.

In Madrid (Spain), Machado *et al*. \[[@B33]\] investigated the existence of class 1 integrons in ESBL-producing in 133 *E. coli* isolates and reported that 39% of the isolates were ESBL producing, and class 1 integrons were more common among 67% of the isolates. Thus, based on their study, a significant relationship was not observed between the spread of genetic elements encoding ESBL and the dispersion of integrons in these isolates.

Karimi *et al.* \[[@B34]\] detected class 1 integrons in ESBL producing in 100 *E. coli* isolates in Tehran, Iran. Thirty *E. coli*isolates were positive for ESBLs, and the frequency of class 1 integrons was 52%. Also, 54% of ESBL producers had class 1 integrons. The detected fragment of *intI1* was 9000 bp.

In a survey by Al-Assil *et al*. \[[@B35]\] in Aleppo (Syria), 61.33% of uropathogenic *E. coli*were ESBL producers, and class 1 integrons were detected in 54.6% of them. Prevalence of class 1 integrons in ESBL isolates was 34%.

In conclusion, this study demonstrates that unlike other researches, the prevalence of class 1 integrons in ESBL producing *E. coli* strains is very common. The results of the current study also indicated that there are at least two resistance mechanisms in our isolates, and they can be transferred to other clinical strains, then it is very important to identify and control the resistant strains. Increased resistance may be related to the lack of proper research, abuse of chemotherapeutic agents, public misuse of antibiotics, and little or no preventive measure. Thus, piperacillin can be used as a therapeutic agent or the most effective antibiotic in controlling UTI infections in the patients infected by ESB-producing *E. coli* carrying class 1 integrons in Rasht (Guilan Province, Iran). Nevertheless, more studies are needed to be performed in this area.

The authors would like to thank the University of Guilan (Iran) for its financial support as well as the staffs from Razi Pathobiology Laboratory for providing samples and for their collaboration in this research.
